Clinical factors related to the aqueous levels of vascular endothelial growth factor and hepatocyte growth factor in proliferative diabetic retinopathy

Reference

• Aiello LM, Cavallerano JD. Ocular complications of diabetes mellitus. In Kahn CR, Weir, GC, eds. Josfinis Diabetes Mellitus. Philadelphia, USA: Lea & Febiger; 1994;771–93.
   Google Scholar
• Kohner E, Henkind P. Correlation of fluorescein angio-gram and retinal digest in diabetic retinopathy. Am J Ophthalmol. 1970;69:403–14.
   PubMed Web of Science ®Google Scholar
• Bresnick GH, Davis MD, Myers FL, de Venecia G. Clinicopathologic correlations in diabetic retinopathy. Am J Ophthalmol. 1977;95:1215–20.
   Google Scholar
• Rand LI. Recent advances in diabetic retinopathy. Am J Med. 1981;70:595–602.
   PubMed Web of Science ®Google Scholar
• Early Treatment Diabetic Retinopathy Study Research Group. Results from the Early Treatment Diabetic Reti-nopathy Study. Ophthalmology. 1991;98(Suppl):741–840.
   Google Scholar
• Alder VA, Cringle SJ, Brown M. The effect of regionalretinal photocoagulation on vitreal oxygen tension. In-vest Ophthalmol Vis Sci. 1987;28:1078–85.
   PubMed Web of Science ®Google Scholar
• Novack RL, Stefansson E, Hatchell DL. The effect of photocoagulation on the oxygenation and ultrastructure of avascular retina. Exp Eye Res. 1990;50:289–96.
   Google Scholar
• Stefansson E, Machemer R, de Juan E Jr, McCuen BW 2nd, Peterson J. Retinal oxygenation and laser treatment in patients with diabetic retinopathy. Am J Ophthalmol. 1992;113:36–8.
   Google Scholar
• Armstrong D, Augustin AJ, Spengler R, Al-Jada A, Nickola T, Grus F, Koch F. Detection of vascular en-dothelial growth factor and tumor necrosis factor alpha in epiretinal membranes of proliferative diabetic re-tinopathy, proliferative vitreoretinopathy and macular pucker. Ophthalmologica. 1998;212:410–4.
   Google Scholar
• Katsura Y, Okano T, Noritake M, Kosano H, Nishigori H, Kado S, Matsuoka T. Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders. Diabetes Care. 1998;21:1759–63.
   PubMed Web of Science ®Google Scholar
• Adamis AP, Miller JW, Bernal MT, D'Amico DJ, Folkman J, Yeo TK, Yeo KT. Increased vascular en-dothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthal-mol. 1994;118:445–50.
   Google Scholar
• Burgos R, Simo R, Audi L, Mateo C, Mesa J, Garcia-Ramirez M, Carrascosa A. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy. Diabetologia. 1997;40:1107–9.
   Google Scholar
• Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL. Vas-cular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480–7.
   PubMed Web of Science ®Google Scholar
• Shinoda K, Ishida S, Kawashima S, Wakabayashi T, Matsuzaki T, Takayama M, Shinmura K, Yamada M. Comparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus. Br J Ophthalmol. 1999;83:834–7.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Morishita R, Higaki J, Kida I, Aoki M, Moriguchi A, Yamada K, Hayashi S, Yo Y, Nakano H, Matsumoto K, Nakamura T, Ogihara, T. Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor. J Hypertens. 1996;14:1067–72.
   PubMed Web of Science ®Google Scholar
• Morishita R, Nakamura S, Nakamura Y, Aoki M, Mori-guchi A, Kida I, Yo Y, Matsumoto K, Nakamura T, Higaki J, Ogihara T. Potential role of an endothelium-specific growth factor, hepatocyte growth factor, on en-dothelial damage in diabetes. Diabetes. 1997;46:138–42.
   Google Scholar
• Nishimura M, Nakano K, Ushiyama M, Nanbu A, Ohtsuka K, Takahashi H, Yoshimura M. Increased se-rum concentrations of human hepatocyte growth factor in proliferative diabetic retinopathy. J Clin Endocrinol Metab. 1998;83:195–8.
   Google Scholar
• Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N, King GL, Smith LE. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using solu-ble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA. 1995;92:10457–61.
   Google Scholar
• Aiello LP, Ferrara N, King GL. Hypoxic regulation and bioactivity of vascular endothelial growth factor: Char-acterization in retinal microvascular pericytes and pig-ment epithelial cells. (Abstract) Invest Ophthalmol Vis Sci. 1994;35(Suppl):1868.
   Google Scholar
• The Diabetic Retinopathy Study Research Group. Pho-tocoagulation treatment of proliferative diabetic retin-opathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. Ophthal-mology. 1991;88: 583–600.
   Google Scholar
• Shima D, Adamis AP, Yeo KT, Yeo TK, Berse B, Brown L. Hypoxic regulation of vascular permeability factor (vascular endothelial growth factor) mRNA and protein secretion by human retinal pigment epithelial cells. (Abstract) Invest Ophthalmol Vis Sci. 1993;34 (Suppl):900.
   Google Scholar
• Miyazawa K, Shimomura T, Kitamura A, Kondo J, Morimoto Y, Kitamura N. Molecular cloning and se-quence analysis of the cDNA for a human serine pro-tease responsible for activation of hepatocyte growth factor. J Biol Chem. 1993;268:10024–8.
   PubMed Web of Science ®Google Scholar
• Matsumoto K, Tajima H, Okazaki H, Nakamura T. Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor-I31 and glucocorticoids. J Biol Chem. 1992;267:24917–20.
   PubMed Web of Science ®Google Scholar
• Nakano N, Morishita R, Moriguchi A, Nakamura Y, Hayashi SI, Aoki M, Kida I, Matsumoto K, Nakamura T, Higaki J, Ogihara T. Negative regulation of local hepatocyte growth factor expression by angiotensin II and transforming growth factor-beta in blood vessels: potential role of HGF in cardiovascular disease. Hyper-tension. 1998;32:444–51.
   Google Scholar
• Nishimura M, Ushiyama M, Nanbu A, Ohtsuka K, Takahashi H, Yoshimura M. Serum hepatocyte growth factor as a possible indicator of arteriosclerosis. J Hy-pertens. 1997;15:1137–42.
   Google Scholar
• Nakamura Y, Morishita R, Nakamura S, Aoki M, Mori-guchi A, Matsumoto K, Nakamura T, Higaki J, Ogihara T. A vascular modulator, hepatocyte growth factor, is associated with systolic pressure. Hypertension. 1996; 28:409–13
   Google Scholar
• Hirase K, Ikeda T, Yasuhara T, Koizumi S, Kinoshita S, Nishimura M. Hepatocyte growth factor in the sub-retinal fluid in rhegmatogenous retinal detachment. (Ab-stract) Invest Ophthalmol Vis Sci. 1999;40(Suppl):5949.
   Google Scholar
• Yasuhara T, Ikeda T, Hirase K, Koizumi S, Kinoshita S, Nishimura M. (1999) Vitreous levels of hepatocyte growth factor in rhegmatogenous retinal detachment. (Abstract) Invest Ophthalmol Vis Sci. 1999;40(Suppl): S949.
   Google Scholar
• Lashkari K, Rahimi N, Kazlauskas A. Hepatocyte growth factor receptor in human RPE cells: Implications in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 1999;40:149–56.
   Google Scholar